131 related articles for article (PubMed ID: 26239623)
21. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Schildhaus HU; Heukamp LC; Merkelbach-Bruse S; Riesner K; Schmitz K; Binot E; Paggen E; Albus K; Schulte W; Ko YD; Schlesinger A; Ansén S; Engel-Riedel W; Brockmann M; Serke M; Gerigk U; Huss S; Göke F; Perner S; Hekmat K; Frank KF; Reiser M; Schnell R; Bos M; Mattonet C; Sos M; Stoelben E; Wolf J; Zander T; Buettner R
Mod Pathol; 2012 Nov; 25(11):1473-80. PubMed ID: 22684217
[TBL] [Abstract][Full Text] [Related]
22. Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas.
Rehkaemper J; Korenkov M; Quaas A; Rueschoff J; Pamuk A; Zander T; Hillmer AM; Buettner R; Hoelscher AH; Bruns CJ; Loeser H; Alakus H; Schoemig-Markiefka B
BMC Cancer; 2020 Jun; 20(1):587. PubMed ID: 32571252
[TBL] [Abstract][Full Text] [Related]
23. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH.
Russell PA; Yu Y; Young RJ; Conron M; Wainer Z; Alam N; Solomon B; Wright GM
Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544
[TBL] [Abstract][Full Text] [Related]
26. FGFR1 expression and gene copy numbers in human lung cancer.
Kohler LH; Mireskandari M; Knösel T; Altendorf-Hofmann A; Kunze A; Schmidt A; Presselt N; Chen Y; Petersen I
Virchows Arch; 2012 Jul; 461(1):49-57. PubMed ID: 22648708
[TBL] [Abstract][Full Text] [Related]
27. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
28. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
[TBL] [Abstract][Full Text] [Related]
30. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
31. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer.
Miao JL; Liu RJ; Zhou JH; Meng SH
Chin Med J (Engl); 2016 Dec; 129(23):2868-2872. PubMed ID: 27901003
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Jung DH; Shin SK; Lee SK; Lee YC; Kim HR; Moon YW; Kim JH; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2015 Feb; 6(4):2562-72. PubMed ID: 25537505
[TBL] [Abstract][Full Text] [Related]
34. Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma.
Costa Raiol LC; Figueira Silva EC; Mendes da Fonseca D; Leal MF; Guimarães AC; Calcagno DQ; Khayat AS; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
Cancer Genet Cytogenet; 2008 Feb; 181(1):31-5. PubMed ID: 18262050
[TBL] [Abstract][Full Text] [Related]
35. FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.
Ahn S; Lee J; Hong M; Kim ST; Park SH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Jung SH; Kang WK; Kim KM
Mod Pathol; 2016 Sep; 29(9):1095-103. PubMed ID: 27230412
[TBL] [Abstract][Full Text] [Related]
36. Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization.
Kiyose S; Nagura K; Tao H; Igarashi H; Yamada H; Goto M; Maeda M; Kurabe N; Suzuki M; Tsuboi M; Kahyo T; Shinmura K; Hattori N; Sugimura H
Pathol Int; 2012 Jul; 62(7):477-84. PubMed ID: 22691185
[TBL] [Abstract][Full Text] [Related]
37. HER2 status in unusual histological variants of gastric adenocarcinomas.
Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
[TBL] [Abstract][Full Text] [Related]
38. [HER2 gene amplification and overexpression in advanced gastric cancer].
Roa I; Slater J; Carvajal D; Schalper K; de Toro G; Ares R; Game A; León J; de Aretxabala X
Rev Med Chil; 2013 Nov; 141(11):1411-9. PubMed ID: 24718467
[TBL] [Abstract][Full Text] [Related]
39. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
[TBL] [Abstract][Full Text] [Related]
40. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
